Surat Pernyataan Direksi Per 30 Juni 2026.pdf

PT MILLENNIUM PHARMACON INTERNATIONAL Tbk

SURAT PERNYATAAN DIREKSI TENTANG
TANGGUNG JAWAB ATAS LAPORAN KEUANGAN
KONSOLIDASIAN INTERIM
UNTUK TAHUN YANG BERAKHIR 30 JUNI 2026
PT MILLENNIUM PHARMACON INTERNATIONAL Tbk
DAN ENTITAS ANAK

DIRECTORS' STATEMENT
REGARDING THE RESPONSIBILITY FOR THE INTERIM
CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2026
PT MILLENNIUM PHARMACON INTERNATIONAL Tbk
'AND ITS SUBSIDIARY

Kami, yang bertanda tangan di bawah ini: We, the undersigned:

Name
Office address

Nama
Alamat kantor

Dr.Imam Fathorrahman MM,
Crown Bungur Arteri Lt, 2-4
JL. Sultan Iskandar Muda No. 18
P3 Kel. Kebayoran Lama Selatan,
Kec. Kebayoran Lama - Jakarta Selatan
Jl Tebet Utara IV B No.3 RT 003/002
Kel. Tebet Timur, Kec. Tebet -
Jakarta Selatan
(62-21) 27085961

Alamat domisili Residential Address

Nomor telepon Phone Number

Jabatan Direktur Utama/ President Director Position
Nama Mohamad Fazly bin Hassan : Name
Alamat kantor Crown Bungur Arteri Lt, 2-4 Office address
JL. Sultan Iskandar Muda No. 18
Kel. Kebayoran Lama Selatan,
Kec. Kebayoran Lama - Jakarta Selatan
Alamat domisili JL Apartement Hamptons Park Residential Address

Tower A Unit 8 F,

Jl Terogong Raya No. 18 Cilandak Barat
(62-21) 27085961
Direktur/ Director

Phone Number
Position

Nomor telepon
Jabatan

menyatakan bahwa: declare that:

1. Kami bertanggung jawab atas penyusunan dan 1.
penyajian laporan keuangan konsolidasian

We are responsible for the preparation and
presentation of the consolidated financial statements

PT Millennium Pharmacon International Tbk dan
entitas anak,

of PT Millennium Pharmacon International Tbk and its
subsidiary,

2. Laporan keuangan konsolidasian PT Millennium 2. The  consolidated financial — statements of
Pharmacon International Tbk dan entitas anak telah PT Millennium Pharmacon International Tbk and its
disusun dan disajikan sesuai dengan Standar subsidiary have been prepared and presented in
Akuntansi Keuangan di Indonesia, accordance with the Financial Accounting Standards

in Indonesia,

3. 3. Semua informasi dalam laporan keuangan 3. a. All information in the consolidated financial
konsolidasian PT Millennium — Pharmacon statements of PT Millennium  Pharmacon
International Tbk dan entitas anak telah dimuat International Tbk and its subsidiary have been
secara lengkap dan benar, disclosed in a complete and truthful manners:

b. Laporan keuangan konsolidasian PT Millennium b. The consolidated financial statements of
Pharmacon International Tbk dan entitas anak PT Millennium Pharmacon International Tbk and
tidak mengandung informasi atau fakta material its subsidiary do not contain misleading material

“ yang tidak benar, dan tidak menghilangkan information or facts, and do not conceal any
informasi atau fakta material, material information or facts:

4. Bertanggung jawab atas sistem pengendalian intern 4. We are responsible for PT Millennium Pharmacon

dalam PT Millennium Pharmacon International Tbk
dan entitas anak.

International Tbk and its subsidiary's internal control
system.

This statement letter is made truthfully.

Demikian pernyataan ini dibuat dengan sebenarnya.

, Jakarta, 30 Juli/July 2026

| Kah

106282112
Dr.Imam Fathorrahman MM
Direktur Utama/ President Director

Mohamad Fazly bin Hassan
Direktur/Director

Crown Bungur Arteri 2-4th Floors
Jl. Sultan Iskandar Muda No. 18, Jakarta 12240, Indonesia
Phone : #6221 27085961